Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2003
09/03/2003CN1120041C Reactor comprising contact tube bundle
09/03/2003CN1119988C Composition for oxidation dyeing of keratin fibres and dyeing process using this composition
09/02/2003US6613942 Glucagon antagonists/inverse agonists
09/02/2003US6613908 Method for carbamoylating alcohols
09/02/2003US6613905 Chemokine receptor antagonists and methods of use therefor
09/02/2003US6613902 Induce biosynthesis of cytokines such as interferons, interleukins, and tumor necrosis factor in humans and in mice.
09/02/2003US6613888 Azo dyes, process for making the same, ink-jet printing ink, ink-jet recording method
09/02/2003US6613794 Inhibiting tumor necrosis factor alpha, treating eosinophil-related condition, treating inflammatory airway disorder
09/02/2003US6613789 Heterocyclo-substituted imidazoles for the treatment of inflammation
09/02/2003US6613784 Cyclooxygenase inhibitors such as 2-acetyloxybenzoic acid 6-(nitroxymethyl)-2-methylpyridinyl ester hydrochloride, having good kinetics, solubility and efficiency; nontoxic
09/02/2003US6613783 Non-systemic control of parasites
09/02/2003US6613781 Potential use in the treatment of a variety of central nervous system disorders such as anxiety, depression, epilepsy, obsessive-compulsive disorders, migraine, congnitive disorders, sleep disorders and schizophrenia
09/02/2003US6613776 Protein serine/threonine kinase inhibitors used for treating diseases such as cancer, diabetes and Alzheimer's disease
09/02/2003US6613773 Pyrimidinyloxyphenyl-3-alkoxypropenoates derivatives
09/02/2003US6613772 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
09/02/2003US6613770 Quinoline derivatives as NK-2 and NK-3 receptor ligands
09/02/2003US6613769 Tryptase inhibitors
09/02/2003US6613572 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
09/02/2003US6613354 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
09/02/2003US6613345 Conjugates of sodium channel blockers and methods of using the same
09/02/2003CA2216796C Quinazoline derivatives
08/2003
08/28/2003WO2003070753A1 Method for producing a powder inhalant containing a salt of the cgrp antagonist bibn4096
08/28/2003WO2003070725A2 Process for preparing indolinone derivatives
08/28/2003WO2003070723A1 5-heteroaryl substituted indoles
08/28/2003WO2003070722A1 Improvement in the production of imidazole derivatives and novel intermediates of the derivatives
08/28/2003WO2003070721A1 2-(2-pyridyl)-5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi
08/28/2003WO2003070710A1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
08/28/2003WO2003070707A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
08/28/2003WO2003070277A1 Antipruritics
08/28/2003WO2003070248A1 Use of 4-(4-methylpiperazin-1-ylmethyl)-n[4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl]-benzamide for treating seminomas
08/28/2003WO2003070247A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
08/28/2003WO2003070244A1 Antagonist of melanin concentrating hormone and their uses
08/28/2003WO2003070242A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003WO2003070184A2 Sodium channel blockers
08/28/2003WO2003070153A2 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
08/28/2003WO2003028641A3 Mch receptor antagonists
08/28/2003WO2003004007A3 Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd)
08/28/2003WO2003002559A3 Piperidine compounds for use as orexin receptor antagonist
08/28/2003WO2003002105A3 Use of tyrosine kinase inhibitors for treating bone loss
08/28/2003WO2002102359A3 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity
08/28/2003US20030162973 Reaction of the diazonium salt of an aminopyridine or aminobenzene in which the benzene ring bears one or more electron-withdrawing groups with a mixture of thionyl chloride in water, in the presence of an electron transfer-catalyst
08/28/2003US20030162972 Pyridyl alkane acid amides as cytostatics and immunosupressives
08/28/2003US20030162970 For use as anti-inflammatory agents
08/28/2003US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
08/28/2003US20030162867 Stabilizer mixtures
08/28/2003US20030162814 Amines such as 2-(3-(N-hydroxyamidino)phenylamino)-N-(2'-sulfamoylbiphenyl-4-yl)-2 -methylpropionamide, used as anticoagulants or for prophylaxis of arteriosclerosis, angina pectoris, restinosis or metastasis
08/28/2003US20030162812 4-haloalkyl-3-heterocyclylpyridines, 4-haloalkyl-5-heterocyclyl-pyrimidines and 4-trifluoromethyl-3-oxadiazolylpyridines, processes for their preparation, compositions comprising them, and their use as pesticides
08/28/2003US20030162811 Heterocyclic amines such as 4-(3'-Thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
08/28/2003US20030162808 Acetindine derivatives, their preparation and medicaments containing them
08/28/2003US20030162790 Benzimidazoles that are useful in treating sexual dysfunction
08/28/2003US20030162787 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
08/28/2003US20030162785 1,3-dihydro-2H-indol- 2-one derivatives
08/28/2003US20030162784 Pyridazinone aldose reductase inhibitors
08/28/2003US20030162780 Administering to a patient with a disease treatable with a muscarinic receptor antagonist a 1,2,3,4-tetrahydro-naphthalene-2-yl-alkylaminoalkyl-piperidine derivative
08/28/2003US20030162777 Administering a biheterocyclic compounds containing aminocarbonyl, aminothiocarbonyl or aminosulfonyl group for treating neuromuscular dysfunction of the lower urinary tract in a mammal in need of such treatment
08/28/2003US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
08/28/2003US20030162775 Heterocyclic substituted pyrazolones
08/28/2003US20030162774 Derivatives of sulfonylurea, sulfonylthiourea, sulfonylguanidine, thioacylsufonamide and acylsulfonamide; useful for treating thromobis
08/28/2003US20030162772 For example, N-(2-(3-((1-(3,4-dichlorobenzylpiperidinyl) aminohydroxypropoxy)phenyl)acetamide; use as modulators of chemokine receptor activity, and may be used in treatment of autoimmune, inflammatory, proliferative diseases
08/28/2003US20030162768 Treatment of Alzheimer's disease
08/28/2003US20030162767 Novel 1,3-dihydro-2h-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them
08/28/2003US20030162766 Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists
08/28/2003US20030162765 Use in treatment and prevention of central nervous system and other disorders
08/28/2003US20030162764 Pyrimidine A2b selective antagonist compounds, their synthesis and use
08/28/2003US20030162690 Bood anticoagulant
08/28/2003CA2477074A1 5-heteroaryl substituted indoles
08/28/2003CA2476936A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
08/28/2003CA2476837A1 Sodium channel blockers
08/28/2003CA2476711A1 Process for preparation of an inhalation powder containing a salt of the cgrp antagonist bibn4096
08/28/2003CA2476406A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
08/28/2003CA2476402A1 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
08/28/2003CA2475455A1 Process for preparing indolinone derivatives
08/28/2003CA2473089A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/27/2003EP1338592A1 Novel 2-phenylpiperazine derivatives
08/27/2003EP1337531A2 Herbicidal heterocycles
08/27/2003EP1337529A2 Heterocyclylalkyl piperidine derivatives, their preparation and compositions containing same
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337526A1 Substituted imidazoles useful in the treatment of inflammatory diseases
08/27/2003EP1337525A1 Process for the crystallization of (r)- or (s)-lansoprazole
08/27/2003EP1337524A1 Substituted quinolines as antitumor agents
08/27/2003EP1337523A2 2,4-substituted pyridine derivatives
08/27/2003EP1337522A1 0ovel farnesyl protein transferase inhibitors
08/27/2003EP1337520A1 Substituted 5-aryl and 5-heteroaryl-2-(2-hydroxyphenyl)-2h-benzotriazole derivatives as uv absorbers
08/27/2003EP1337517A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
08/27/2003EP1337513A1 4-substituted quinolines as antitumor agents
08/27/2003EP1337512A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
08/27/2003EP1337508A1 Preparation of sodium-hydrogen exchanger type-1 inhibitors
08/27/2003EP1337255A2 Use of p38 inhibitors for the treatment of inflammation-enhanced cough
08/27/2003EP1337253A1 Novel compounds
08/27/2003EP1337251A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
08/27/2003EP1337150A2 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
08/27/2003EP1193266B1 Quinolinecarboxylic acid derivative or salts thereof
08/27/2003EP1165547B1 Substituted benzoylpyrazoles as herbicides
08/27/2003EP1095039B1 New pharmaceutically active compounds
08/27/2003EP1007520B1 2-aminopyridines containing fused ring substituents as nos inhibitors
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/27/2003EP0862552B1 Succinimide and maleimide cytokine inhibitors
08/27/2003EP0739342B1 Pyridine modulators of acetylcholine receptors
08/27/2003CN1439006A Novel compounds possessing antibacterial, antifungal or antitumor activity
08/27/2003CN1439005A Pyrrole substituted 2-indolinone protein kinase inhibitors
1 ... 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 ... 1080